Joshua Silva, MD Nov 7, 2025 13 min read Updated: Apr 17 Medically authored by Joshua Silva, MD | Evidence-Based Weight Loss at Potere Health MD As GLP-1 and GLP-1/GIP medications such as semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) continue to transform medical weight management, one question comes up repeatedly: Do these medications cause muscle lossor even muscle wasting
(C) , high CKD risk patients
The math is clean and predictable because the 5mg/ml concentration divides evenly into standard insulin syringe markings
Semaglutide, a GLP-1 receptor agonist , is widely used to support weight management through appetite suppression
Microdosing is also used in many traditional therapies, and just as the name suggests, it means taking a very small amount of a medication compared to the standard dose